Trials / Unknown
UnknownNCT01365676
GAMALINE®+HIPERICIN® for PMS Treatment and Vasomotor Symptoms
Phase 3 Study Efficacy and Tolerance: The Use of 2 Phytomedicines in Association GAMALINE® 900mg + HIPERICIN® 300mg for the Treatment of Pre-Menstrual Syndrome (PMS) and Vasomotor Symptoms
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Phytopharm Consulting Brazil · Network
- Sex
- Female
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
2 phytomedicines already in the market: GAMALINE® for premenstrual syndrome and HIPERICIN® as antidepressant will be prescribed together for treating women with Premenstrual Syndrome (PMS) symptoms and vasomotor problems for checking the advantage compared to the GAMALINE® prescription alone.
Detailed description
Test with 2 female groups: 25-44 years old (reproductive age) and 45-55 years old (climacteric premenopausal age) complaining about all symptoms related with premenstrual syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GAMALINE® + HIPERICIN® | GAMALINE® 900mg + HIPERICIN 300mg T0 = 2 soft caps of each / day (1st month) T1-T6 = 1 soft caps of each / day (2nd - 6th month) |
| DRUG | GAMALINE® | GAMALINE® 900mg T0= 2 soft caps / day (1st month) T1-T6 = 1 soft caps / day (2nd - 6th month) |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2012-10-01
- Completion
- 2012-12-01
- First posted
- 2011-06-03
- Last updated
- 2011-12-06
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01365676. Inclusion in this directory is not an endorsement.